Sensient Technologies Corporation (SXT)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NYSE
Market Cap: $4.97B
Last updated: Nov 17, 2026 at 11:06 AM ET
Sensient Technologies Corporation (SXT) Stock Forecast
Analysts expect Sensient Technologies (SXT) to earn $4.19 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.80B. Of 5 analysts, 3 rate the stock Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 2.20, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 60% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 20.0% |
| Buy | 2 | 40.0% |
| Hold | 2 | 40.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 5
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 17.7% and revenue estimates rise 12.2%.
- Fiscal year ending Dec 31, 2026
- $4.19
- EPS consensus, revenue $1.80B
- Fiscal year ending Dec 31, 2027
- $4.93
- EPS consensus, revenue $2.02B
- Next report
- Feb 11, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $4.19 | $4.16 to $4.20 | 5 | $1.80B | $1.80B to $1.80B | 5 |
| Dec 31, 2027 | $4.93 | $4.86 to $5.01 | 5 | $2.02B | $1.97B to $2.05B | 5 |
Quarterly Estimates
The EPS consensus rises from $0.85 for the quarter ending Dec 31, 2026 to $1.24 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.85 | $0.81 to $0.88 | 4 | $449.02M | $433.65M to $471.35M | 5 |
| Mar 31, 2027 | $1.24 | $1.24 to $1.24 | 1 | $483.70M | $483.70M to $483.70M | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 2 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 1.7% from $4.12.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $4.19 | $4.18 | $4.18 | $4.18 | $4.12 | +1.7% |
| Fiscal year ending Dec 31, 2027 | $4.93 | $4.99 | $4.99 | $4.96 | $4.90 | +0.7% |
| Quarter ending Mar 31, 2027 | $1.24 | N/A | N/A | $1.21 | $1.21 | +2.6% |
Frequently Asked Questions About SXT
What is the SXT stock forecast?
Consensus analyst estimates put Sensient Technologies's EPS at $4.19 for the fiscal year ending Dec 31, 2026, on revenue of $1.80B. The consensus rating from 5 analysts is Buy.
How do analysts rate SXT stock?
Of 5 analysts covering Sensient Technologies, 1 rates it Strong Buy, 2 Buy, 2 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from SXT next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $4.19, with estimates from $4.16 to $4.20 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $4.93, with estimates from $4.86 to $5.01 from 5 analysts.
What revenue do analysts expect from Sensient Technologies next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.80B, with estimates from $1.80B to $1.80B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $2.02B, with estimates from $1.97B to $2.05B.
How many analysts cover SXT?
5 analysts rate Sensient Technologies stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
SXT pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors